Comparison of the Efficacy and Safety of Sacubitril/Valsartan versus Ramipril in Patients with ST-Segment Elevation Myocardial Infarction

The role of sacubitril/valsartan in patient with heart failure (HF) is established. Whether sacubitril/valsartan plays a role in improving outcomes in patients after ST-segment elevation myocardial infarction (STEMI) is unknown. The current study aims to comparing the efficacy and safety of sacubitril/valsartan versus ramipril in post-STEMI patients. Patients presenting with STEMI were randomized to receive either sacubitril/valsartan or ramipril after primary percutaneous coronary intervention (PCI).
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research